Brainomix® Stroke Imaging Solution Improves Consistency of Image Interpretation for Doctors

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

OXFORD, England, June 21, 2019 /PRNewswire/ — e-CTA®, developed by Brainomix, provides fast, consistent collateral assessments powered by AI and Deep Learning, based on CTA analysis. The recently published CATS study showed that e-CTA® provides a real-time and fully automated approach to collateral scoring, with the potential to improve consistency of image interpretation.

New Study concludes that e-CTA proves to be useful for consistent patient selection in clinical practice (PRNewsfoto/Brainomix)New Study concludes that e-CTA proves to be useful for consistent patient selection in clinical practice (PRNewsfoto/Brainomix)

The study demonstrated the high sensitivity and specificity of e-CTA®, independent of clinician input. This is very important especially when selecting ischemic stroke patients presenting symptoms beyond 6 hours or with an uncertain time of onset, as reflected in the recent European Stroke Organisation guidelines for mechanical thrombectomy. Expert neuroradiology input is rarely available in real-time at most hospitals around the world, especially at primary stroke centres from which patients need to be transferred to a comprehensive centre. Even when specialist neuroradiology opinion is readily available, e-CTA® offers the opportunity to improve inter-rater reliability, therefore helping select the right patients that can benefit the most from mechanical thrombectomy.

Dr George Harston, Brainomix Chief Medical and Innovation Officer & Consultant Stroke Physician, Oxford University Hospitals NHSFT stated: “The importance of good collateral blood flow for patient outcome in acute stroke treatment is well recognised. However, even expert collateral scores commonly suffer from inter-rater error. In this exciting study Brainomix has shown once again the value of AI to augment human performance. In this study, e-CTA improved consistency between neuroradiologists when used as a decision support tool. Even when used as a standalone tool e-CTA produced similar scores compared to experts, opening up the opportunity for reliable collateral assessment for all patients regardless of which hospital they attend.”

Read the full study here.

View original content to download multimedia:http://www.prnewswire.com/news-releases/brainomix-stroke-imaging-solution-improves-consistency-of-image-interpretation-for-doctors-300872748.html

SOURCE Brainomix

Staff

Recent Posts

Psyence BioMed Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

New York, New York--(Newsfile Corp. - April 17, 2025) - Psyence Biomedical Ltd. (NASDAQ: PBM)…

8 hours ago

Performant Survey Spotlights Top Healthcare Technology Initiatives

PLANTATION, Fla.--(BUSINESS WIRE)--At HIMSS25, Performant Healthcare, Inc. (Nasdaq: PHLT) (the “Company” or “Performant”), a leader…

10 hours ago

IgniteData Appoints Dr. Jose Galvez as Chief Medical Information Officer to Accelerate Clinical Data Innovation

NEW CASTLE, Del., April 17, 2025 /PRNewswire/ -- IgniteData, the leader in eSource to sponsor…

10 hours ago

Ansys to Release First Quarter 2025 Earnings on April 30, 2025

PITTSBURGH, April 17, 2025 /PRNewswire/ -- ANSYS, Inc. (NASDAQ: ANSS) announced today that the Company…

10 hours ago

ERPHealth partners with Penn State to help prevent substance use disorder

PHILADELPHIA, April 17, 2025 /PRNewswire/ -- The Edna Bennett Pierce Prevention Research Center (PRC) at…

10 hours ago

Groundbreaking Study on Omega-3 DHA Enriched Foods to Enhance Public Health in Saudi Arabia

RIYADH, Saudi Arabia, April 17, 2025 /PRNewswire/ -- In a significant advancement for public health,…

10 hours ago